Patents by Inventor Jeff Schwegman

Jeff Schwegman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
    Publication number: 20070010486
    Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 11, 2007
    Inventors: Jeff Schwegman, Mark Edgar, Branimir Sikic, Daniel Hoth, David Socks, Scott Glenn, John Marcelletti, Michael Walsh, Pratik Multani
  • Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
    Publication number: 20070010487
    Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 11, 2007
    Inventors: Jeff Schwegman, Mark Edgar, Branimir Sikic, Daniel Hoth, David Socks, Scott Glenn, John Marcelletti, Michael Walsh, Pratik Multani
  • Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
    Publication number: 20070010485
    Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 11, 2007
    Inventors: Jeff Schwegman, Mark Edgar, Branimir Sikic, Daniel Hoth, David Socks, Scott Glenn, John Marcelletti, Michael Walsh, Pratik Multani